Verotoxin induces hemorrhagic lesions in rat small intestine - Temporal alteration of vasoactive substances

Hirokazu Tashiro, Soichiro Miura, Iwao Kurose, Dai Fukumura, Hidekazu Suzuki, Makoto Suematsu, Masahiro Yoshioka, Masaharu Tsuchiya, Akemi Kai, Yasuo Kudoh

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

E. coli O157:H7 produces a cytotoxin active against Vero cells that has been termed verotoxin. In this study, we demonstrated that local intraarterial injection of verotoxin induced a decrease in blood flow and an increase in hemorrhagic lesions in rat small intestine. Significant increases in the area of hemorrhagic lesions were observed at 120 min after verotoxin injection. These lesions were produced by either verotoxin 1 or 2, but verotoxin 2 produced more extensive lesions. The temporal alteration of vasoactive substances in microcirculatory beds was determined after the administration of culture filtrate of E. coli O157:H7. Tissue-type plasminogen activator activity in regional plasma was significantly elevated as early as 30 min, suggesting that local fibrinolytic activation mediated by microvascular endothelium occurred. There was also early elevation of platelet-activating factor content in the ileal mucosa and its level remained significantly elevated thereafter. Intestinal blood flow, as determined by a laser Doppler flowmeter, started to decrease at about 45 min. The platelet-activating factor antagonist CV6209 was shown to attenuate the decrease in blood flow as well as the development of hemorrhagic lesions, demonstrating that platelet-activating factor is an important mediator for the microcirculatory damage. Accumulation of neutrophils demonstrated by myeloperoxidase activity in the intestinal mucosa and overproduction of oxygen-radicals from neutrophils of the mesenteric veins determined by the luminol-dependent chemiluminescence assay were observed at 60 min, corresponding with the decreased blood flow. Platelet-activating factor may be closely involved in the process of leukocyte accumulation and increased oxygen radical generation, because CV6209 also significantly attenuated these changes. Verotoxin is considered to induce vascular endothelial cell damage and elicit the accumulation of neutrophils in intestinal microvascular beds, leading to hemorrhagic lesions via mediators including tissue-type plasminogen activator, platelet-activating factor, and oxygen-derived free radicals.

Original languageEnglish
Pages (from-to)1230-1238
Number of pages9
JournalDigestive Diseases and Sciences
Volume39
Issue number6
DOIs
Publication statusPublished - 1994 Jun

Fingerprint

Shiga Toxins
Platelet Activating Factor
Small Intestine
Neutrophils
Escherichia coli O157
Tissue Plasminogen Activator
Reactive Oxygen Species
Shiga Toxin 2
Intra-Arterial Injections
Mesenteric Veins
Flowmeters
Luminol
Vero Cells
Cytotoxins
Intestinal Mucosa
Luminescence
Peroxidase
Free Radicals
Endothelium
Mucous Membrane

Keywords

  • intestinal mucosal blood flow
  • neutrophils
  • oxygen radicals
  • platelet-activating factor
  • tissue-type plasminogen activator
  • verotoxin

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Tashiro, H., Miura, S., Kurose, I., Fukumura, D., Suzuki, H., Suematsu, M., ... Kudoh, Y. (1994). Verotoxin induces hemorrhagic lesions in rat small intestine - Temporal alteration of vasoactive substances. Digestive Diseases and Sciences, 39(6), 1230-1238. https://doi.org/10.1007/BF02093788

Verotoxin induces hemorrhagic lesions in rat small intestine - Temporal alteration of vasoactive substances. / Tashiro, Hirokazu; Miura, Soichiro; Kurose, Iwao; Fukumura, Dai; Suzuki, Hidekazu; Suematsu, Makoto; Yoshioka, Masahiro; Tsuchiya, Masaharu; Kai, Akemi; Kudoh, Yasuo.

In: Digestive Diseases and Sciences, Vol. 39, No. 6, 06.1994, p. 1230-1238.

Research output: Contribution to journalArticle

Tashiro, H, Miura, S, Kurose, I, Fukumura, D, Suzuki, H, Suematsu, M, Yoshioka, M, Tsuchiya, M, Kai, A & Kudoh, Y 1994, 'Verotoxin induces hemorrhagic lesions in rat small intestine - Temporal alteration of vasoactive substances', Digestive Diseases and Sciences, vol. 39, no. 6, pp. 1230-1238. https://doi.org/10.1007/BF02093788
Tashiro, Hirokazu ; Miura, Soichiro ; Kurose, Iwao ; Fukumura, Dai ; Suzuki, Hidekazu ; Suematsu, Makoto ; Yoshioka, Masahiro ; Tsuchiya, Masaharu ; Kai, Akemi ; Kudoh, Yasuo. / Verotoxin induces hemorrhagic lesions in rat small intestine - Temporal alteration of vasoactive substances. In: Digestive Diseases and Sciences. 1994 ; Vol. 39, No. 6. pp. 1230-1238.
@article{eedf390c64a44495afd0b8b6e1a7edd2,
title = "Verotoxin induces hemorrhagic lesions in rat small intestine - Temporal alteration of vasoactive substances",
abstract = "E. coli O157:H7 produces a cytotoxin active against Vero cells that has been termed verotoxin. In this study, we demonstrated that local intraarterial injection of verotoxin induced a decrease in blood flow and an increase in hemorrhagic lesions in rat small intestine. Significant increases in the area of hemorrhagic lesions were observed at 120 min after verotoxin injection. These lesions were produced by either verotoxin 1 or 2, but verotoxin 2 produced more extensive lesions. The temporal alteration of vasoactive substances in microcirculatory beds was determined after the administration of culture filtrate of E. coli O157:H7. Tissue-type plasminogen activator activity in regional plasma was significantly elevated as early as 30 min, suggesting that local fibrinolytic activation mediated by microvascular endothelium occurred. There was also early elevation of platelet-activating factor content in the ileal mucosa and its level remained significantly elevated thereafter. Intestinal blood flow, as determined by a laser Doppler flowmeter, started to decrease at about 45 min. The platelet-activating factor antagonist CV6209 was shown to attenuate the decrease in blood flow as well as the development of hemorrhagic lesions, demonstrating that platelet-activating factor is an important mediator for the microcirculatory damage. Accumulation of neutrophils demonstrated by myeloperoxidase activity in the intestinal mucosa and overproduction of oxygen-radicals from neutrophils of the mesenteric veins determined by the luminol-dependent chemiluminescence assay were observed at 60 min, corresponding with the decreased blood flow. Platelet-activating factor may be closely involved in the process of leukocyte accumulation and increased oxygen radical generation, because CV6209 also significantly attenuated these changes. Verotoxin is considered to induce vascular endothelial cell damage and elicit the accumulation of neutrophils in intestinal microvascular beds, leading to hemorrhagic lesions via mediators including tissue-type plasminogen activator, platelet-activating factor, and oxygen-derived free radicals.",
keywords = "intestinal mucosal blood flow, neutrophils, oxygen radicals, platelet-activating factor, tissue-type plasminogen activator, verotoxin",
author = "Hirokazu Tashiro and Soichiro Miura and Iwao Kurose and Dai Fukumura and Hidekazu Suzuki and Makoto Suematsu and Masahiro Yoshioka and Masaharu Tsuchiya and Akemi Kai and Yasuo Kudoh",
year = "1994",
month = "6",
doi = "10.1007/BF02093788",
language = "English",
volume = "39",
pages = "1230--1238",
journal = "American Journal of Digestive Diseases",
issn = "0002-9211",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Verotoxin induces hemorrhagic lesions in rat small intestine - Temporal alteration of vasoactive substances

AU - Tashiro, Hirokazu

AU - Miura, Soichiro

AU - Kurose, Iwao

AU - Fukumura, Dai

AU - Suzuki, Hidekazu

AU - Suematsu, Makoto

AU - Yoshioka, Masahiro

AU - Tsuchiya, Masaharu

AU - Kai, Akemi

AU - Kudoh, Yasuo

PY - 1994/6

Y1 - 1994/6

N2 - E. coli O157:H7 produces a cytotoxin active against Vero cells that has been termed verotoxin. In this study, we demonstrated that local intraarterial injection of verotoxin induced a decrease in blood flow and an increase in hemorrhagic lesions in rat small intestine. Significant increases in the area of hemorrhagic lesions were observed at 120 min after verotoxin injection. These lesions were produced by either verotoxin 1 or 2, but verotoxin 2 produced more extensive lesions. The temporal alteration of vasoactive substances in microcirculatory beds was determined after the administration of culture filtrate of E. coli O157:H7. Tissue-type plasminogen activator activity in regional plasma was significantly elevated as early as 30 min, suggesting that local fibrinolytic activation mediated by microvascular endothelium occurred. There was also early elevation of platelet-activating factor content in the ileal mucosa and its level remained significantly elevated thereafter. Intestinal blood flow, as determined by a laser Doppler flowmeter, started to decrease at about 45 min. The platelet-activating factor antagonist CV6209 was shown to attenuate the decrease in blood flow as well as the development of hemorrhagic lesions, demonstrating that platelet-activating factor is an important mediator for the microcirculatory damage. Accumulation of neutrophils demonstrated by myeloperoxidase activity in the intestinal mucosa and overproduction of oxygen-radicals from neutrophils of the mesenteric veins determined by the luminol-dependent chemiluminescence assay were observed at 60 min, corresponding with the decreased blood flow. Platelet-activating factor may be closely involved in the process of leukocyte accumulation and increased oxygen radical generation, because CV6209 also significantly attenuated these changes. Verotoxin is considered to induce vascular endothelial cell damage and elicit the accumulation of neutrophils in intestinal microvascular beds, leading to hemorrhagic lesions via mediators including tissue-type plasminogen activator, platelet-activating factor, and oxygen-derived free radicals.

AB - E. coli O157:H7 produces a cytotoxin active against Vero cells that has been termed verotoxin. In this study, we demonstrated that local intraarterial injection of verotoxin induced a decrease in blood flow and an increase in hemorrhagic lesions in rat small intestine. Significant increases in the area of hemorrhagic lesions were observed at 120 min after verotoxin injection. These lesions were produced by either verotoxin 1 or 2, but verotoxin 2 produced more extensive lesions. The temporal alteration of vasoactive substances in microcirculatory beds was determined after the administration of culture filtrate of E. coli O157:H7. Tissue-type plasminogen activator activity in regional plasma was significantly elevated as early as 30 min, suggesting that local fibrinolytic activation mediated by microvascular endothelium occurred. There was also early elevation of platelet-activating factor content in the ileal mucosa and its level remained significantly elevated thereafter. Intestinal blood flow, as determined by a laser Doppler flowmeter, started to decrease at about 45 min. The platelet-activating factor antagonist CV6209 was shown to attenuate the decrease in blood flow as well as the development of hemorrhagic lesions, demonstrating that platelet-activating factor is an important mediator for the microcirculatory damage. Accumulation of neutrophils demonstrated by myeloperoxidase activity in the intestinal mucosa and overproduction of oxygen-radicals from neutrophils of the mesenteric veins determined by the luminol-dependent chemiluminescence assay were observed at 60 min, corresponding with the decreased blood flow. Platelet-activating factor may be closely involved in the process of leukocyte accumulation and increased oxygen radical generation, because CV6209 also significantly attenuated these changes. Verotoxin is considered to induce vascular endothelial cell damage and elicit the accumulation of neutrophils in intestinal microvascular beds, leading to hemorrhagic lesions via mediators including tissue-type plasminogen activator, platelet-activating factor, and oxygen-derived free radicals.

KW - intestinal mucosal blood flow

KW - neutrophils

KW - oxygen radicals

KW - platelet-activating factor

KW - tissue-type plasminogen activator

KW - verotoxin

UR - http://www.scopus.com/inward/record.url?scp=0028237763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028237763&partnerID=8YFLogxK

U2 - 10.1007/BF02093788

DO - 10.1007/BF02093788

M3 - Article

C2 - 8200255

AN - SCOPUS:0028237763

VL - 39

SP - 1230

EP - 1238

JO - American Journal of Digestive Diseases

JF - American Journal of Digestive Diseases

SN - 0002-9211

IS - 6

ER -